1 Coroneos CJ, Selber JC, Offodile AC 2nd, Butler CE, Clemens MW. US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients. Ann Surg. 2019;269(1):30–36. doi:10.1097/
SLA.0000000000002990.
2 Hillard C, Fowler JD, Barta R, Cunningham B. Silicone breast implant rupture: a review. Gland Surg.
2017;6(2):163–168. doi:10.21037/gs.2016.09.12.
3 Ohishi Y, Mitsuda A, Ejima K, et al. Breast implant-associated anaplastic large-cell lymphoma: first case
detected in a Japanese breast cancer patient. Breast Cancer. 2020;27(3):499–504. doi:10.1007/s12282-02001064-5.
4 Japan Society of Plastic and Reconstructive Surgery. Key points of breast implant-associated anaplastic large
cell lymphoma [in Japanese]. https://jsprs.or.jp/member/committee/breast-implant-guideline/bia-alcl. Accessed
October 2, 2020.
5 Handel N, Garcia ME, Wixtrom R. Breast implant rupture: causes, incidence, clinical impact, and management. Plast Reconstr Surg. 2013;132(5):1128–1137. doi:10.1097/PRS.0b013e3182a4c243.
6 Kim B, Roth C, Young VL, et al. Anaplastic large cell lymphoma and breast implants: results from
a structured expert consultation process. Plast Reconstr Surg. 2011;128(3):629–639. doi:10.1097/
PRS.0b013e31821f9f23.
7 Gidengil CA, Predmore Z, Mattke S, van Busum K, Kim B. Breast implant-associated anaplastic
large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015;135(3):713–720. doi:10.1097/
PRS.0000000000001037.
8 Kaplan J, Rohrich R. Breast implant illness: a topic in review. Gland Surg. 2021;10(1):430–443.
doi:10.21037/gs-20-231.
9 Hölmich LR, Lipworth L, McLaughlin JK, Friis S. Breast implant rupture and connective tissue
disease: a review of the literature. Plast Reconstr Surg. 2007;120(7 Suppl 1):62S-69S. doi:10.1097/01.
prs.0000286664.50274.f2.
10 Swezey E, Shikhman R, Moufarrege R. Breast Implant Rupture. In: StatPearls [Internet]. Treasure Island
(FL): StatPearls Publishing; date unknown. https://www.ncbi.nlm.nih.gov/books/NBK459308. Accessed
January 21, 2022.
References End
Nagoya J. Med. Sci. 85. 852–856, 2023
856
doi:10.18999/nagjms.85.4.852
...